abstract |
This invention pertains to a method of preventing cancer in humans or other animals by administering to the human or other animals ginsenosides Rh2, Rh3, aglycon ginsenosides, or any combination thereof. These ginsenosides and aglycon ginsenosides prevent or reduce the chances of developing cancer or precancerous malignancies by inhibiting the activities of cytochrome p450 enzymes. This invention also pertains to pharmaceutical and nonpharmaceutical compositions for the prevention of cancer in humans or other animals. |